Riskpilot← Back to searchSign inGet full accessMEDICVISION AS
ASActiveOrg 997571703Parkveien 4, 4838 ArendalAndre helsetjenester · NACE 86909Est. 20113 employees
Revenue 2022
NOK 10,1M
+106% vs 2021
EBITDA margin
0.7%
+104% vs 2021
Equity ratio
-32.6%
Financial strength
Net profit 2022
NOK -206K
+89% vs 2021
| Revenue | NOK 10,1M | +106% |
| EBITDA | NOK 75K | +104% |
| Net profit | NOK -206K | +89% |
| Total assets | NOK 8,1M | -6% |
| Equity | NOK -2,6M | -8% |
| Employees | 3 | — |
Legal name
MEDICVISION AS
Org number
997571703
Legal form
Aksjeselskap
NACE code
86909 · Andre helsetjenester
Founded
9. november 2011
Share capital
NOK 31 000 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Spesialfirma som leverer kunnskap og produkter innen syn, sport og helse. Selskapet driver i tillegg med engroshandel av sykepleie- og apotekvarer, sportsutstyr og optiske artikler.
Address
Parkveien 4, 4838 Arendal
Phone
+4737033100
Email
mail@medicvision.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 635 | 894 | 1 679 | 4 500 | 5 459 | 5 532 | 5 742 | 10 246 | 6 773 | 4 900 | 10 097 |
| Staff expenses | −0 | −103 | −307 | −1 172 | −2 155 | −2 026 | −2 134 | −1 024 | −3 247 | −1 509 | −2 954 | −2 069 |
| EBITDA | −264 | 312 | 264 | −366 | −2 990 | −3 515 | −1 846 | 533 | −1 312 | −1 979 | −1 981 | 75 |
| Depreciation & amort. | −0 | −7 | −5 | −15 | −193 | −267 | −255 | −254 | −249 | −126 | −0 | −0 |
| EBIT | −264 | 305 | 260 | −381 | −3 183 | −3 782 | −2 101 | 279 | −1 561 | −2 105 | −1 981 | 75 |
| Net financials | 0 | 0 | −0 | −29 | −98 | −154 | −159 | −228 | −641 | −500 | −319 | −344 |
| Profit before tax | −264 | 305 | 260 | −410 | −3 281 | −3 937 | −2 260 | 50 | −2 201 | −2 605 | −2 300 | −269 |
| Tax | −77 | 85 | 75 | −0 | −0 | −1 457 | −282 | 92 | −274 | −551 | −501 | −63 |
| Net profit | −187 | 220 | 185 | −410 | −3 281 | −2 480 | −1 978 | −42 | −1 928 | −2 054 | −1 799 | −206 |
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 344 | 733 | 740 | 1 665 | 4 147 | 4 813 | 4 875 | 7 025 | 11 927 | 6 616 | 8 641 | 8 079 |
| Equity | 56 | 110 | 103 | −307 | −3 589 | 209 | −115 | −157 | 1 422 | −628 | −2 427 | −2 634 |
| Long-term debt | 0 | 0 | 0 | 0 | 500 | 900 | 3 059 | 5 345 | 2 484 | 3 729 | 6 369 | 7 449 |
| Short-term debt | 288 | 623 | 637 | 1 472 | 7 236 | 3 703 | 1 931 | 1 837 | 8 020 | 3 515 | 4 699 | 3 264 |
| Total debt | 288 | 623 | 637 | 1 972 | 7 736 | 4 603 | 4 990 | 7 183 | 10 504 | 7 244 | 11 068 | 10 713 |
EBITDA margin
0.7%
This company
15.8%
Market median
-96% vs market
20112022
Equity ratio
-32.6%
This company
38.2%
Market median
-185% vs market
20112022
Return on equity
-20624500.0%
This company
18.4%
Market median
-112089774% vs market
20112022
Net profit margin
-2.0%
This company
8.1%
Market median
-125% vs market
20112022
Asset turnover
1.25×
This company
1.12×
Market median
+12% vs market
20112022
Debt / equity
4.07×
This company
0.62×
Market median
-556% vs market
20112022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-10-10 – 2011-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KV Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2014 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
MEDICVISION AS | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ivarion Holding As
MEDICVISION AS Board members of MEDICVISION AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kenneth Vik Lund | Chief Executive Officer | 0 companies |
| Rolf Lund | Chairman | 0 companies |